Re-irradiation alternatives for recurrent high-grade glioma (Review)
- Authors:
- Yuanli Dong
- Chengrui Fu
- Hui Guan
- Tianyi Zhang
- Zicheng Zhang
- Tao Zhou
- Baosheng Li
-
Affiliations: Sixth Department of Radiation Oncology, Shandong Cancer Hospital, Jinan, Shandong 250117, P.R. China - Published online on: August 1, 2016 https://doi.org/10.3892/ol.2016.4926
- Pages: 2261-2270
-
Copyright: © Dong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al: European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Bauman GS, Sneed PK, Wara WM, Stalpers LJ, Chang SM, McDermott MW, Gutin PH and Larson DA: Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys. 36:433–441. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Combs SE, Gutwein S, Thilmann Ch, Huber P, Debus J and Schulz-Ertner D: Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. J Neurooncol. 74:167–171. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Voynov G, Kaufman S, Hong T, Pinkerton A, Simon R and Dowsett R: Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol. 25:606–611. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Kim B, Soisson E, Duma C, Chen P, Hafer R, Cox C, Cubellis J, Minion A, Plunkett M and Mackintosh R: Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy. Clin Neurol Neurosurg. 113:509–512. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
McKenzie JT, Guarnaschelli JN, Vagal AS, Warnick RE and Breneman JC: Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas. J Neurooncol. 113:403–409. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fokas E, Wacker U, Gross MW, Henzel M, Encheva E and Engenhart-Cabillic R: Hypofractionated stereotactic reirradiation of recurrent glioblastomas: A beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol. 185:235–240. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Archavlis E, Tselis N, Birn G, Ulrich P, Baltas D and Zamboglou N: Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: A retrospective cohort analysis of recurrent glioblastoma multiforme. BMJ Open. 3:e0022622013. View Article : Google Scholar : PubMed/NCBI | |
|
Combs SE, Gutwein S, Thilmann C, Debus J and Schulz-Ertner D: Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT). Strahlenther Onkol. 181:768–773. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Vordermark D, Kölbl O, Ruprecht K, Vince GH, Bratengeier K and Flentje M: Hypofractionated stereotactic re-irradiation: Treatment option in recurrent malignant glioma. BMC Cancer. 5:552005. View Article : Google Scholar : PubMed/NCBI | |
|
Henke G, Paulsen F, Steinbach JP, Ganswindt U, Isijanov H, Kortmann RD, Bamberg M and Belka C: Hypofractionated reirradiation for recurrent malignant glioma. Strahlenther Onkol. 185:113–119. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Elliott RE, Parker EC, Rush SC, Kalhorn SP, Moshel YA, Narayana A, Donahue B and Golfinos JG: Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. World Neurosurg. 76:128–140; discussion 61-62. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Cuneo KC, Vredenburgh JJ, Sampson JH, Reardon DA, Desjardins A, Peters KB, Friedman HS, Willett CG and Kirkpatrick JP: Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 82:2018–2024. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Larson DA, Suplica JM, Chang SM, Lamborn KR, McDermott MW, Sneed PK, Prados MD, Wara WM, Nicholas MK and Berger MS: Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro Oncol. 6:119–126. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Darakchiev BJ, Albright RE, Breneman JC and Warnick RE: Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme. J Neurosurg. 108:236–242. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Cannon GM, Tomé WA, Robins HI and Howard SP: Pulsed reduced dose-rate radiotherapy: Case report: A novel re-treatment strategy in the management of recurrent glioblastoma multiforme. J Neurooncol. 83:307–311. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Pellettieri L, HStenstam B, Rezaei A, Giusti V and Sköld K: An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme. Acta Neurol Scand. 117:191–197. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA and Clark HB: Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys. 45:1133–1141. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Combs SE, Thilmann C, Edler L, Debus J and Schulz-Ertner D: Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution. J Clin Oncol. 23:8863–8869. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Combs SE, Bischof M, Welzel T, Hof H, Oertel S, Debus J and Schulz-Ertner D: Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol. 89:205–210. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
MaierHauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V and Jordan A: Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 103:317–324. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Minniti G, Armosini V, Salvati M, Lanzetta G, Caporello P, Mei M, Osti MF and Maurizi RE: Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma. J Neurooncol. 103:683–691. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hundsberger T, Brügge D, Putora PM, Weder P, Weber J and Plasswilm L: Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol. 112:133–139. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Flieger M, Ganswindt U, Schwarz SB, Kreth FW, Tonn JC, la Fougère C, Ertl L, Linn J, Herrlinger U, Belka C and Niyazi M: Re-irradiation and bevacizumab in recurrent high-grade glioma: An effective treatment option. J Neurooncol. 117:337–345. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Liem B J, Holland J M, Kang M Y, Hoffelt SC and Marquez CM: Karnofsky Performance Status assessment: Resident versus attending. J Cancer Educ. 17:138–141. 2002.PubMed/NCBI | |
|
Chinot OL, Wick W and Cloughesy T: Bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 370:20492014. View Article : Google Scholar : PubMed/NCBI | |
|
Shepherd SF, Laing RW, Cosgrove VP, Warrington AP, Hines F, Ashley SE and Brada M: Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys. 37:393–398. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M and Nieder C: Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 63:511–519. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
ErnstStecken A, Ganslandt O, Lambrecht U, Sauer R and Grabenbauer G: Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol. 81:287–294. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J and Abrey LE: Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 75:156–163. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B and Ryu S: Salvage reirradiation for recurrent glioblastoma with radiosurgery: Radiographic response and improved survival. J Neurooncol. 92:185–191. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, Evans JJ, Hyslop T, Pequignot E, Downes B, et al: Hypofractionated stereotactic radiation therapy: An effective therapy for recurrent high-grade gliomas. J Clin Oncol. 28:3048–3053. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Minniti G, Scaringi C, De Sanctis V, Lanzetta G, Falco T, Di Stefano D, Esposito V and Enrici RM: Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas. J Neurooncol. 111:187–194. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shapiro LQ, Beal K, Goenka A, Karimi S, Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE and Gutin PH: Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma. Int J Radiat Oncol Biol Phys. 85:636–642. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wuthrick EJ, Curran WJ Jr, Camphausen K, Lin A, Glass J, Evans J, Andrews DW, Axelrod R, Shi W, Werner-Wasik M, et al: A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma. Int J Radiat Oncol Biol Phys. 90:369–375. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chalmers AJ, Ruff EM, Martindale C, Lovegrove N and Short SC: Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent. Int J Radiat Oncol Biol Phys. 75:1511–1519. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Den RB, Kamrava M, Sheng Z, WernerWasik M, Dougherty E, Marinucchi M, Lawrence YR, Hegarty S, Hyslop T, Andrews DW, et al: A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys. 85:321–328. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shrieve DC, Alexander E III, Wen PY, Fine HA, Kooy HM, Black PM and Loeffler JS: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery. 36:275–284. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons JP, Rohr M and Clark HB: Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol. 13:1642–1648. 1995.PubMed/NCBI | |
|
Combs SE, Widmer V, Thilmann C, Hof H, Debus J and Schulz-Ertner D: Stereotactic radiosurgery (SRS): Treatment option for recurrent glioblastoma multiforme (GBM). Cancer. 104:2168–2173. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Maranzano E, Anselmo P, Casale M, Trippa F, Carletti S, Principi M, Loreti F, Italiani M and Caserta C: Treatment of recurrent glioblastoma with stereotactic radiotherapy: Long-term results of a mono-institutional trial. Tumori. 97:56–61. 2011.PubMed/NCBI | |
|
Torok JA, Wegner RE, Mintz AH, Heron DE and Burton SA: Re-irradiation with radiosurgery for recurrent glioblastoma multiforme. Technol Cancer Res Treat. 10:253–258. 2011.PubMed/NCBI | |
|
Conti A, Pontoriero A, Arpa D, Siragusa C, Tomasello C, Romanelli P, Cardali S, Granata F, De Renzis C and Tomasello F: Efficacy and toxicity of CyberKnife re-irradiation and ‘dose dense’ temozolomide for recurrent gliomas. Acta Neurochir (Wien). 154:203–209. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Skeie BS, Enger PØ, Brøgger J, Ganz JC, Thorsen F, Heggdal JI and Pedersen PH: γknife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurg. 78:658–669. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Cabrera AR, Cuneo KC, Desjardins A, Sampson JH, McSherry F, Herndon JE II, Peters KB, Allen K, Hoang JK, Chang Z, et al: Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: A prospective trial. Int J Radiat Oncol Biol Phys. 86:873–879. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Martínez-Carrillo M, Tovar-Martín I, Zurita-Herrera M, Del Moral-Ávila R, Guerrero-Tejada R, Saura-Rojas E, Osorio-Ceballos JL, Arrebola-Moreno JP and Expósito-Hernández J: Salvage radiosurgery for selected patients with recurrent malignant gliomas. Biomed Res Int. 2014:6579532014. View Article : Google Scholar : PubMed/NCBI | |
|
Mayer R and Sminia P: Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys. 70:1350–1360. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Simon JM, Cornu P, Boisserie G, Hasboun D, Tep B, Hardiman C, Valery CA, Delattre JY, Dormont D, Baillet F and Mazeron JJ: Brachytherapy of glioblastoma recurring in previously irradiated territory: Predictive value of tumor volume. Int J Radiat Oncol Biol Phys. 53:67–74. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Barani IJ and Larson DA: Radiation therapy of glioblastoma. Cancer Treat Res. 163:49–73. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Tatter SB, Shaw EG, Rosenblum ML, Karvelis KC, Kleinberg L, Weingart J, Olson JJ, Crocker IR, Brem S, Pearlman JL, et al: An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: Multicenter safety and feasibility trial. J Neurosurg. 99:297–303. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD and Kleinberg L: Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Int J Radiat Oncol Biol Phys. 62:1133–1139. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter SP, Patel A, Amin P, Lustig R, et al: GliaSite brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis. Neurosurgery. 58:701–709. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tselis N, Kolotas C, Birn G, Röddiger S, Filipowicz I, Kontova M, Fountzilas G, Selviaridis P, Baltas D, Heyd R, et al: CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results. Strahlenther Onkol. 183:563–570. 2007. View Article : Google Scholar | |
|
Fabrini MG, Perrone F, De Franco L, Pasqualetti F, Grespi S, Vannozzi R and Cionini L: Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas. Strahlenther Onkol. 185:524–529. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kickingereder P, Hamisch C, Suchorska B, Galldiks N, VisserVandewalle V, Goldbrunner R, Kocher M, Treuer H, Voges J and Ruge MI: Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: Single-center experience with 201 cases. J Neurooncol. 120:615–623. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gregg EC, Yau TM and Kim SC: Effect of low dose rate radiation on cell growth kinetics. Biophys J. 28:81–91. 1979. View Article : Google Scholar : PubMed/NCBI | |
|
Koot RW, Maarouf M, Hulshof MC, Voges J, Treuer H, Koedooder C, Sturm V and Bosch DA: Brachytherapy: Results of two different therapy strategies for patients with primary glioblastoma multiforme. Cancer. 88:2796–2802. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Archavlis E, Tselis N, Birn G, Ulrich P and Zamboglou N: Salvage therapy for recurrent glioblastoma multiforme: A multimodal approach combining fluorescence-guided resurgery, interstitial irradiation and chemotherapy. Neurol Res. 36:1047–1055. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Adkison JB, Tomé W, Seo S, Richards GM, Robins HI, Rassmussen K, Welsh JS, Mahler PA and Howard SP: Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy. Int J Radiat Oncol Biol Phys. 79:835–841. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Mishima Y, Honda C, Ichihashi M, Obara H, Hiratsuka J, Fukuda H, Karashima H, Kobayashi T, Kanda K and Yoshino K: Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet. 2:388–389. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Sun T, Zhang Z, Li B, Chen G, Xie X, Wei Y, Wu J, Zhou Y and Du Z: Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem/progenitor cells in vitro. Radiat Oncol. 8:1952013. View Article : Google Scholar : PubMed/NCBI | |
|
Miyatake S, Kawabata S, Yokoyama K, Kuroiwa T, Michiue H, Sakurai Y, Kumada H, Suzuki M, Maruhashi A, Kirihata M and Onoc K: Survival benefit of boron neutron capture therapy for recurrent malignant gliomas. Appl Radiat Isot. 67(7-8 Suppl): S22–S24. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Miyatake S, Kawabata S, Hiramatsu R, Furuse M, Kuroiwa T and Suzuki M: Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: Four cases. Radiat Oncol. 9:62014. View Article : Google Scholar : PubMed/NCBI | |
|
DeBin JA, Maggio JE and Strichartz GR: Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am J Physiol. 264:C361–C369. 1993.PubMed/NCBI | |
|
Mamelak AN, Rosenfeld S, Bucholz R, Raubitschek A, Nabors LB, Fiveash JB, Shen S, Khazaeli MB, Colcher D, Liu A, et al: Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol. 24:3644–3650. 2006. View Article : Google Scholar : PubMed/NCBI |
